Formulating antitrust guidelines for API sector a key task of China's reform plan this year
MLex Summary: Formulating a set of antitrust guidelines for the active pharmaceutical-ingredients sector is among the key tasks of the Chinese government in deepening reforms of the country’s medical and healthcare...To view the full article, register now.
Already a subscriber? Click here to view full article